trending Market Intelligence /marketintelligence/en/news-insights/trending/m2tjs6x6mpis-om0gm0o_g2 content esgSubNav
In This List

Takeda appoints CFO

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Takeda appoints CFO

Takeda Pharmaceutical Co. Ltd. said Costa Saroukos will be appointed as CFO, effective April 1.

Saroukos is currently CFO at the company's Europe and Canada Business Unit.

He replaces James Kehoe, who will resign as CFO on March 31, and as a director on May 31.

Kehoe has been appointed executive vice president and global CFO of Walgreens Boots Alliance Inc., effective June 1.